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Nitrogen dioxide (NO'.,) is often present in inhaled air and ,nay be generated in viva from tfitrie oxide. Exposure of human blood plasma to NO~ 
caused rapid los~es of as¢orbic acid, uric acid and protein thiol groups, as well as lipid peroxidation and depletions ofcz-to¢opherol, bilirabia and 
ubiqninol-10. No increase in protein carbonyls was detected. $ttpplementation f plasma with ascorbate decreased the rules of lipid pero~idation, 
0:-tocopherol del~letion and 1o~5 of uric acid. Uric acid supplementation decreased rat¢~ of lipid peroxidation but not the loss ofcx-toeopherol, We 
conclude Ihat a~corbic acid, protein -SH groups, uric a~:id and ~z-tocophcrol may be important agents protecting against NO~ in viva. If these 
antioxidants are depleted, peroxidation of lipids occurs and might contribute to the toxicity of NO'.,. 
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1. INTRODUCTION 
Nitrogen dioxide (NO~) is a powerfully-oxidizing re- 
active brown gas with established pulmonary toxicity 
[1-6]. It can be present in homes with unrented heating 
sources at concentrations up to 2 ppm, in mainstream 
cigarette smoke (>50 ppm), in smog (up to 1 ppm) and 
in smoke from other burning organic materials [6-8]. 
NO] might also be formed in viva by reaction of O2 with 
nitric oxide (NO"), which is generated (as the 'endothe- 
lium-derived relaxing factor') by vascular endothelial 
ceils, and also by other cell types (reviewed in [9]). Nitric 
oxide might also react with superoxide (O~-) radical in 
viva to give peroxynitrite, which decomposes to yield 
NO] [10]. There is considerable current interest in the 
toxicity and matagenicity c,fnitrogen oxides [1-8,11,12]. 
NO] possesses an unpaired electron and is thus a tree 
radical [13]. For e×ample, NO] can stimulate lipid per- 
oxidation, and end-products ofperoxidation are present 
in the lung lining fluids of rats after NO'~ exposure [14-- 
16]. NO~, can also damage proteins [6] and it is not yet 
clear which targets of attack by NO.,' are the most im- 
portant in viva. Also, human body fluids and tissues 
contain a wide range of antioxidant defence systems 
(reviewed in [17,18]), and it seems likely that they might 
offer some protection against damage by NO.,'. Thus any 
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NO.~ formed from NO" (by reaction with O,) in viva will 
presumably react with antioxidants in human extracel- 
lular fluids. Inhaled N O~ probably undergoes consider- 
able interaction with antioxidants and other constitu- 
ents of ltmg lining fluids [19]. However, the relative 
importance of different antioxidant defenees in protect- 
ing against NO~ has not yet been established, although 
several authors have suggested that ct-tocopherol may 
be important [20,21]. 
In the present paper, we have investigated the reac- 
tion of NO.~ with antioxidants in freshly-prepared 
human plasma as a model for both situations [22], espe- 
cially as methods tbr measuring antioxidants and oxida- 
tive damage in plasma are well-established 
[17,18,22,23]. We attempted to measure NO~-induced 
oxidative damage in several ways: loss of protein -SH 
groups, inactivation of enzymes, formation of protein 
carbony!s [24] and formation of lipid hydroperoxides, 
as measured by a specific HPLC-based chemilumines- 
cence method [23,25]. 
2. EXPERIMENTAL 
2.1. Materials 
All r~a/~ents were or the highest quality available from Sigma. Blood 
from healthy adult male vohmtecrs was collected into heparinized 
tube~ and centrifuged at 1,000 × g and 4°C Ibr 10 rain to obtain 
plasma, which was used immediately, 
2.2. Exposure to NO'., 
Plasma waz diluted 80:20 with 0.5 M KH~_POa/K2HPO.~ buffer, pH 
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7.4, to maintain pH durin~ exposures toNO~. A correction I)as becn 
made for this dilution factor in the resnlts presented. 3 ml aliquots 
were placed into 6 ntl Falcon plates (3 cm diameter) ina controlled. 
environment exposure chamber (Primate Center, UC Davis) in which 
a steady concentration f 14 ppm ofNO: was maintained. NO~ was 
generated by bubbling, nitrogen through the liquid dinner, N.,O4, held 
at 0~C [26]. The NO~, (in N.,) was conveyed tothe mixing inlet of the 
chamber through stainless.steel lines. Flow waz automatically con- 
trolled with a mass flow controller (Tyhm General. Torrance, CA; 
Model FC.2900KZ). Chamber NO, concentration was monitored 
wilh a ehemiluminescent oxide of nitrogen analyzer (Dasibi Corp., 
Glendale, CA; Model 2108). The monitor was calibrated by gas-phase 
titration of ozone with nitric oxide [27] and periodically checked 
against nitric oxide span 8as of known coneentratlon. Hmnidity was 
40-60% and temperature 25-27°C. Plasma liquots were also inca. 
bated for the same time periods in an identical cltamber containing 
filtered air. At the end of the ezposure, the plates were removed, the 
volume o1' plasma diluted back to 3 ml (if necessary) with distilled 
water and aliquots taken for the various assays. 
2.3. As~.a.).s of aatioxidattts 
Ascorbie acid, uric a~id and lipid hydropero~ides w re measured by 
HPLC [25], as was ~-toeopherol [28]. Plasma sulflo'dryl (-SH) groups 
were dmernained using Ellman's reagent. 5,5'.dithiobis(2-nitrobenzo- 
ate). DTNB. Fifty pl of plasma was mixed with i.0 ml of 0.1 M Tris 
barfer, containinB |0 mM EDTA, pH 8.2, Any absorban¢c at 412 nm 
contributed by the plasma lone was subtracted from that obtained 
from the same sample 20 rain aller addition of 40/~l of 10 mM DTNB. 
A blank containing DTNB only was also included, and -SH concen- 
tration was calculated using a molar extinction coeHici~nt of 13,600 
M-~.cm -~ at 412 nm. Protein carbonyls were measar~ Slx~tro- 
photometrically b a modification [29] of the method in [24]. Total 
bilirubin was measured by asin~ aBeckman 5ynchron CX4 atttoana- 
lyzer, as were the activities of lactate dehydrogenase, aspartate ami- 
notran~ferase, ~'-Blutamyltransferase and creatine kinase. 
in some xperiments, he effect of NO~ exposure upon the eleetro- 
phoretic migration of phtsma lipoproteins was examined by agarose 
gel electrophoresis o f NO'.,-exposed or air-exposed plasma, usinB Beck- 
man Paragon Lipid gels run according to the manufacturer's recom- 
mendations. Gels were ztained wlth fat 7B stain. 
3. RESULTS 
Freshly-prepared human plasma was exposed to 14 
ppm NO_~ for variouz times. The value of 14 ppm may 
seem high in relation to the concentrations of NO] re- 
ported in polluted air (usually < l ppm), but it was used 
because the surface:volume ratio in our Falcon plates 
is far lower than the enormous ratio found in the respi- 
ratory tract. In addition, such high NO', concentrations 
are found in mainstream cigarette smoke and smoke 
from other burning organic materials [6-8] and might 
also be achieved in the vicinity of activated phagocytes 
[l 1,12]. We buffered the plasma against pH changes by 
adding a small amount of concentrated phosphate 
buffer. 
Exposure of human plasma to NO~. produced a rapid 
loss ofaseorbic acid, uric acid and protein -SH groups. 
In percentage t rms, aseorbic acid was always lost at the 
greatest rate, with uric acid being lost sliglatiy more 
slowly (reproducible in 8 different experiments utilizing 
plasma from 5 different donors). Fig. 1 shows a repre- 
sentative xperiment. However, one must also consider 
the fact that the concentration of aseorbie acid in 
plasma is much lower than that of uric acid or protein 
-SH [17]. For example, after l h exposure to 14 ppm 
NO], the following losses of antioxidants were observed 
(mean ~ SD for 5 different plasma samples): aseorbate 
49.9 + 15.8/aM0 uric acid 118 ± 41/,tM and protein -SH 
groups 76 + 48/~M. These results are corrected for the 
slow losses observed in the air-exposed controls (Fig. l). 
Hence all three antioxidants appear to make a signifi- 
cant contribution to scavenging NO], but uric acid 
seems to be quantitatively the most important. 
Exposure of plasma to NO-, for 1 h led to the Ibrma- 
tion of lipid hydroperoxides and loss of 0t-toeopherol 
(Fig. I D). Lipid peroxidation and loss of ct-toeopherol 
accelerated after 3 h exposure, when ascorbate and uric 
acid had been almost completely lost. Cholesterol ester 
hydroperoxides were the major species formed (mean -± 
SD, 2.9 +_ 1.8 btM for 3 different plasma samples after 
6 h exposure to NO]), whereas levels of phospholipid 
hydroperoxides in the saree experiments were only 
0.03-0.18/IM. There was also loss of ubiquinol, another 
lipid-soluble antioxidant [30,31], in NO.X-exposed 
plasma. For example, whereas 6 h of exposure to NO.~ 
depleted ~Xotocopherol in haman plasma from 40.6 + 5.7 
/.tM (mean + SD, 5 different plasma samples) to 20.5 +_ 
4.0/.tM, ubiquinol was completely lost (0.95 + 0.05 buM 
to zero; n = 3). 
The starting concentrations of ascorbic acid in 
plasma samples from different donors varied from 34 
/.tM to 227/,tM (the latter in a subject consuming vita- 
min C supplements). Inspection of the data suggested 
that the initial rate of uric acid depletion, but not that 
of protein -SH,  was slower in p~z~mas containing the 
higher ascorbate concentrations '~'he effect of adding 
additional aseorbate to plasma upon the rates of oxida- 
tive damage and antioxidant depletion was therefore 
examined. Fig. 1 shows a represenlative experiment 
using 1 mM added ascorbate. Added ascorbate (1 mM) 
was oxidized fast by NO.~, but zome :¢mained even alter 
5 h exposure (Fig. IA). This ascorbate supplementation 
greatly slowed the NO.~-induced loss of uric acid (Fig. 
IC); it also reproducibly slowed the accumulation of 
lipid hydroperoxides and the loss of a-tocopherol (Fig. 
I D). By contrast, aseorbate addition had no significant 
effect upon the loss of  protein -SH groups (Fig. IS). 
Lower ascorbate concentrations (0.2-0,5 raM) were 
also protective, but to a lesser extent (data not shown). 
The effects of supplementing plasma with uric acid and 
OSH were also examined. GSH, an antioxidant known 
to be present in lining fluids of the lower respiratory 
tract [32,33], did not inhibit lipid peroxidation or tx- 
tocopherol depletion, even when added at I mM final 
concentrations. By contrast, addin~ an additional 0.5 
mM uric acid to plasma ,,,.,,,,,,,~,,,,a . . . . . . .  a ,),,,~,,,. -~,,,-~nt ra t io ,~.  ...... of  
total lipid hydroperoxides after exposure to NO~ for 
6 h by a mean of 55% in two eaperiments. However, 
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Fig, 1, Eflb¢ls ofcxposh~g plasma to NO.,', A representative experiment isshown in which all measurements were made on lhe same plasma samples, 
Each data point is tl~e mean or at least duplicate determinations that difi;:ted by <10%. (A) Los5 of a~corbic acid, (e) NO.~; (m) NO;, plasma 
supplemented with an additional 1 mM a~corbic acid; (o) air-exposed control; (_3) air control + aseorbate. (B) SulfhTdryl groups. (e) NO,': (I) 1~O; 
~- I mM ascorbate; (o) air control; (r~) air ÷ .'tseorbate, (C) Uric acid, (e) ?qO~: (B) NO" + 1 mM ascorbale; (o) air control; (r~) air + a~corbate. 
{D) Upper lines: 0~-toeopherol, (I) NO~-exposed; (e) NO,', plasma supplemented with an additional I mM aseorbic acid. Lower lines: cholesterol 
e~ter hydropcroxidc ( oncentration at 6 h NO~ exposure denoted as 100%); (.,) NO~-enpo~gd; (,t)NO~ + I mM ascorbate, There wa~ no significant 
romlation of lipid hydroperoxidc or depletion of a-to¢opherol in air-c~posed controb. 
uric acid did not significantly affect the loss of a-toco- 
pherol. 
The carbonyl assay, which measures oxidative dam- 
age to several ,~mino acid residues in proteins [24], was 
used to look for NOi-induced protein damage involving 
amino acid residues other than -SH. Reaction oi" NO.~ 
with plasma led to the formation of a pale yellow-or- 
ange chromogen. When allowance was made for this, 
no increase in protein carbonyis was detected even after 
64 
exposure of" plasma to NO~ for 6 h. Similarly, this 6 h 
NO.~ exposure produced no changes in the electro., 
phoretie mobility of plasma low-density lipoproteins 
(LDL) when comp,'ired with air-exposed controls, nor 
did it change the activities of the enzymes lactate dehy- 
drogenase, aspartate aminotransferase and gammaglu- 
tamyl transferase in plasma. Creatine kinase aedvity 
was slightly but reproducibly decreased (by 16 _ 5%~ 
n=3) by 6 h of exposur,~ to NO~.. This exposure al~o 
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decreased total plasma bilirubin from 0.8 +_. 0.4 mg/di 
(n=3) to 0.3 +_. 0.2 mffdl. 
4. DISCUSSION 
In the present paper, we have studied the reaction of 
NO~ with human plasma to gain information about the 
possible lhtes of NO~. generated in rive (e.g. from en- 
dogenous NO" [10]) and of NO] present in polluted 
inhaled air. Ascorbic acid, protein -SH groups and 
especially uric acid all appear to be important scaven- 
gers of NO'.,, being rapidly depleted when plasma is 
exposed to this gas. Addition of extra aseorbate to 
plasma slowed loss ofttric acid. Indeed, 1 mM ascorbate 
appeared to reproducibly increase plasma uric acid con- 
centrations in the early stages of NO~ exposure (by 11 
__ 14%, n=50 after 30 min), for an unknown reason. This 
prevention of uric acid loss may occur because ascorbie 
acid is oxidized faster than uric acid (Fig. 1) and so 
"spares' uric acid. An additional reason may he that 
reaction of NO'., (a free radical) with uric acid produces 
a uric acid radical that can be re-converted to uric acid 
by ascorbate: such a 'recycling' of uric acid radicals has 
been demonstrated i~a vitro [34~35]. 
It is frequently suggested that NO~. toxicity involves 
lipid peroxidation [1,5,6,14015,21036]. Ourdata are con- 
sistent with this view° in that exposure of plasma to 14 
ppm NO] led to peroxidation of lipids and depletion of 
the lipid-soluble antioxidants ubiquinolq0 and ct-toco- 
pherol. Supplementing plasma with ascorbic acid 
slowed the loss ofct-tocopheroi. Ascorbate could act by 
preferentially scavenging NO'.,, so protecting the lipid. 
Aseorbate also recycles a-toeopherol radicals back to 
0t-tocopherol. Adding additional uric acid also slowed 
lipid peroxidation, perhaps by preferentially scavenging 
NO~, but it did not preserve ~x.tocopherol. Bycontrast, 
apart from the rapid loss of protein -SH groups° little 
evidence for NO~..ind uced Oxidative damage to proteins 
was provided by measurements of enzyme inactivation 
or protein carbonyl formation. 
Although we observed NO]-inducz.~! lipid peroxida- 
tion in plasma under our experimental conditions, there 
were no cha ages in the electrophoretic mobility of LDL, 
despite the fact that peroxidation of LDL frequently 
causes uch changes [37]. This could mean that insuffi- 
cient peroxides were formed in the LDL, or that the 
peroxides were not decomposed into aldehydes that 
could modify apoprotein B and change the electro- 
phoretic mobility of the LDL [37]. Further work is 
needed to investigate hese possibilities. 
It is interesting to compare the effects of NO'., on 
plasma with those exerted by another common air-pol- 
lutant, the non.radical ozone (O3). Uric acid, ascorbic 
acid and protein -SH are again important scavensers 
of 0 3 in plasma [22]. Uric acid has been ~uggested to
play a particularly-important scavenging role against 
O~ in the human upper respiratory tract ~22,38]: our 
data suggest that it may also be protective against NO~_. 
However, exposure to O~ produced little lipid peroxida- 
tion in plasma in our previous experiments, whereas 
significant protein damage was detected by the carbonyl 
ass~y [22,39], Hence, inhaled O~ and NO~_ may attack 
different molecular targets in vivo. Perhaps this is rele- 
vant to suggestions that inhalation of mixtures of these 
gases produces ynergistic biological damage [40]. 
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